DC Field | Value | Language |
dc.contributor.author | Șcerbatiuc, Cristina | - |
dc.date.accessioned | 2025-03-18T07:31:45Z | - |
dc.date.available | 2025-03-18T07:31:45Z | - |
dc.date.issued | 2024 | - |
dc.identifier.citation | ȘCERBATIUC, Cristina. Management of diabetic retinopathy in pregnancy. In: Revista de Ştiinţe ale Sănătăţii din Moldova = Moldovan Journal of Health Sciences. 2024, vol. 11, nr. 3, pp. 54-58. ISSN 2345-1467. DOI: https://doi.org/10.52645/MJHS.2024.3.08 | en_US |
dc.identifier.issn | 2345-1467 | - |
dc.identifier.uri | https://mjhs.md/journal/september-2024 | - |
dc.identifier.uri | https://doi.org/10.52645/MJHS.2024.3.08 | - |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/30094 | - |
dc.description.abstract | Introduction. The onset and development of diabetic retinopathy are more common during pregnancy. Pregnancy has no
long-term effect on diabetic retinopathy; however, in 50-70% of cases, changes in retinopathy continues. The probability of
worsening is highest in the second trimester and up to one year postpartum. Additional factors that have been associated
with disease progression include duration of diabetes, the degree of retinopathy at the time of conception, management
of hyperglycemia, anemia, and development of associated hypertension. In cases of severe non-proliferative retinopathy, it
is recommended to promptly initiate laser photocoagulation rather than wait for early proliferative changes. Maintaining
good diabetic control before and during pregnancy can help prevent disease progression and serious vision loss.
Material and methods. Diabetic retinopathy management in pregnancy was the subject of a comprehensive review of the
scientific and medical literature. A structured search was performed in the PubMed, Scopus and HINARI databases, considering
relevant articles published in the last 10 years. The search terms used (in English) were: „Diabetic retinopathy”;
„pregnancy”; „laser photocoagulation”; „intravitreal steroids”; „anti-vascular endothelial growth factor”.
Results. It is suggested that women with diabetes receive pre-conception and post-pregnancy counselling from a
multidisciplinary team including an ophthalmologist, endocrinologist, and perinatologist, as diabetic retinopathy may
worsen during pregnancy. The risk of progression of the disease and the importance of appropriate metabolic control
before and during pregnancy should be clearly explained to the patient. Careful monitoring is required in patients with
advanced gestation, significant retinopathy, concomitant hypertension, and nephropathy.
Conclusion. The risk of retinopathy development may increase during pregnancy. Serious effects can arise for both
the mother and the fetus, even though retinopathy is not common during pregnancy. It is possible to avoid significant
retinopathy by carefully planning a young diabetic woman’s pregnancy and proceeding promptly to laser photocoagulate
in cases of severe non-proliferative retinopathy. A tendency for regress is frequently seen in diabetic retinopathy during the
post-natal period. Subsequent pregnancies do not significantly increase the risk of progression if the retinopathy is stable
before pregnancy. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova | en_US |
dc.relation.ispartof | Revista de Științe ale Sănătății din Moldova = Moldovan Journal of Health Sciences | en_US |
dc.subject | pregnancy | en_US |
dc.subject | diabetic retinopathy | en_US |
dc.subject | laser photocoagulation | en_US |
dc.subject | anti-vascular endothelial growth factor | en_US |
dc.subject | intravitreal steroids | en_US |
dc.subject.ddc | UDC: 617.735-002-02:616.379-008.64:618.2 | en_US |
dc.title | Management of diabetic retinopathy in pregnancy | en_US |
dc.type | Article | en_US |
Appears in Collections: | Revista de Științe ale Sănătății din Moldova : Moldovan Journal of Health Sciences 2024 Vol. 11, Issue 3
|